Castle Biosciences (CSTL) EBITDA (2018 - 2026)
Castle Biosciences (CSTL) EBITDA from Jun 30, 2018 to Mar 31, 2026. The TTM Castle Biosciences (CSTL) EBITDA is -$18M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Castle Biosciences (CSTL) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -35.56% |
| 5 Years TTM | +10.30% |
| All Time TTM | +35.75% |
Annual EBITDA change of Castle Biosciences (CSTL)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$14M | +609.80% |
| 2025 | -$2.04M | -108.27% |
| 2024 | $25M | -144.33% |
| 2023 | -$56M | -10.69% |
| 2022 | -$62M | +69.92% |
| 2021 | -$37M | +504.12% |
| 2020 | -$6.07M | -179.04% |
| 2019 | $7.68M | -316.34% |
| 2018 | -$3.55M | N/A |
Comparison Castle Biosciences (CSTL) five years EBITDA CAGR with competitors
Castle Biosciences (CSTL) five years EBITDA CAGR is 10.29%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PRPH | ProPhase Labs Inc | 73.15% | +611.07% |
| MEDP | Medpace Holdings Inc | 25.16% | +144.57% |
| ISPC | iSpecimen Inc | 25.14% | +144.36% |
| PSNL | Personalis Inc | 18.83% | +83.01% |
| WAT | Waters Corp | 17.45% | +69.66% |
| BNR | Burning Rock Biotech Ltd | 17.26% | +67.79% |
| ICLR | Icon Plc | 12.53% | +21.82% |
| IDXX | Idexx Laboratories Inc | 11.66% | +13.37% |
| MTD | Mettler-Toledo International Inc | 9.87% | -4.08% |
| MYNZ | Mainz Biomed N.V. | 9.82% | -4.54% |
| IQV | IQVIA Holdings Inc | 9.14% | -11.12% |
| RDNT | Radnet Inc | 8.38% | -18.49% |
| IMDX | Insight Molecular Diagnostics Inc | 7.62% | -25.97% |
| ILMN | Illumina Inc | 5.98% | -41.84% |
| A | Agilent Technologies Inc | 5.87% | -42.98% |
| GH | Guardant Health Inc | 5.67% | -44.88% |
| NTRA | Natera Inc | 3.35% | -67.43% |
| TWST | Twist Bioscience Corp | 2.84% | -72.40% |
| BDSX | Biodesix Inc | 2.43% | -76.34% |
| SHC | Sotera Health Company | 2.32% | -77.44% |
| QGEN | Qiagen NV | 2.21% | -78.56% |